Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TPF as 1st-line Chemotherapy in Metastatic Esophageal Cancer
NCT00209690Phase 2Completed
- Sponsor
- Hokkaido Gastrointestinal Cancer Study Group
- Start
- Oct 2003
- Primary completion
- Dec 2009
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of docetaxel, Cisplatin micelle injection (HA132), fluorouracil in esophageal cancer, sponsored by Hokkaido Gastrointestinal Cancer Study Group. Started Oct 2003; status: completed.
02
Drugs
docetaxelCisplatin micelle injection (HA132)fluorouracil
03
Conditions
esophageal cancer
Beyond the preview
Go deeper on NCT00209690.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00209690.